Medexus Pharmaceuticals Inc
TSX:MDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
CA |
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
M
|
Monster Beverage Corp
SWB:MOB
|
US |
|
W
|
Westport Fuel Systems Inc
NASDAQ:WPRT
|
CA |
|
I
|
Inno Instrument Inc
KOSDAQ:215790
|
KR |
|
A
|
AB Science SA
F:A8D
|
FR |
|
Z
|
Zimmer Biomet Holdings Inc
DUS:ZIM
|
US |
|
U
|
Umicore SA
OTC:UMICF
|
BE |
Wall St Price Targets
MDP Price Targets Summary
Medexus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for MDP is 7.14 CAD with a low forecast of 6.06 CAD and a high forecast of 8.4 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MDP's stock price target?
Price Target
7.14
CAD
According to Wall Street analysts, the average 1-year price target for MDP is 7.14 CAD with a low forecast of 6.06 CAD and a high forecast of 8.4 CAD.
What is the Revenue forecast for Medexus Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 12 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 4 years is 11%.
What is the Gross Profit forecast for Medexus Pharmaceuticals Inc?
Projected CAGR
18%
The compound annual growth rate for Gross Profit over the next 4 years is 18%.
What is the Operating Income forecast for Medexus Pharmaceuticals Inc?
Projected CAGR
37%
The compound annual growth rate for Operating Income over the next 4 years is 37%.
What is the Pre-Tax Income forecast for Medexus Pharmaceuticals Inc?
Projected CAGR
170%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 170%.
What is the Net Income forecast for Medexus Pharmaceuticals Inc?
Projected CAGR
122%
The compound annual growth rate for Net Income over the next 3 years is 122%.
